JOHANNESBURG (Reuters) - Pfizer said it could deliver its COVID-19 vaccine, which requires ultra-cold temperatures for storage and distribution, directly to points of vaccination in South Africa.
South Africa is scrambling to secure supplies after the AstraZeneca vaccine it planned to use to kick off its immunisation campaign had greatly reduced efficacy against the COVID-19 virus variant now dominant in the country.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!